Literature DB >> 16538700

Analysis of cluster randomized cross-over trial data: a comparison of methods.

Rebecca M Turner1, Ian R White, Tim Croudace.   

Abstract

In a cluster randomized cross-over trial, all participating clusters receive both intervention and control treatments consecutively, in separate time periods. Patients recruited by each cluster within the same time period receive the same intervention, and randomization determines order of treatment within a cluster. Such a design has been used on a number of occasions. For analysis of the trial data, the approach of analysing cluster-level summary measures is appealing on the grounds of simplicity, while hierarchical modelling allows for the correlation of patients within periods within clusters and offers flexibility in the model assumptions. We consider several cluster-level approaches and hierarchical models and make comparison in terms of empirical precision, coverage, and practical considerations. The motivation for a cluster randomized trial to employ cross-over of trial arms is particularly strong when the number of clusters available is small, so we examine performance of the methods under small, medium and large (6, 18, 30) numbers of clusters. One hierarchical model and two cluster-level methods were found to perform consistently well across the designs considered. These three methods are efficient, provide appropriate standard errors and coverage, and continue to perform well when incorporating adjustment for an individual-level covariate. We conclude that choice between hierarchical models and cluster-level methods should be influenced by the extent of complexity in the planned analysis. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16538700     DOI: 10.1002/sim.2537

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  38 in total

1.  The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality.

Authors:  Sarah J Arnup; Andrew B Forbes; Brennan C Kahan; Katy E Morgan; Joanne E McKenzie
Journal:  Trials       Date:  2016-12-06       Impact factor: 2.279

2.  Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.

Authors:  Anthony K Yartel; David B Rein; Kimberly Ann Brown; Katherine Krauskopf; Omar I Massoud; Cynthia Jordan; Natalie Kil; Alex D Federman; David R Nerenz; Joanne E Brady; Danielle L Kruger; Bryce D Smith
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

Review 3.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 2-Analysis.

Authors:  Elizabeth L Turner; Melanie Prague; John A Gallis; Fan Li; David M Murray
Journal:  Am J Public Health       Date:  2017-05-18       Impact factor: 9.308

4.  Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core.

Authors:  Andrea J Cook; Elizabeth Delong; David M Murray; William M Vollmer; Patrick J Heagerty
Journal:  Clin Trials       Date:  2016-05-13       Impact factor: 2.486

5.  Methodological issues in the design and analyses of neonatal research studies: Experience of the NICHD Neonatal Research Network.

Authors:  Abhik Das; Jon Tyson; Claudia Pedroza; Barbara Schmidt; Marie Gantz; Dennis Wallace; William E Truog; Rosemary D Higgins
Journal:  Semin Perinatol       Date:  2016-06-22       Impact factor: 3.300

6.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Todd W Rice
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

7.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Jonathan P Wanderer; Jesse M Ehrenfeld; Li Wang; Daniel W Byrne; Joanna L Stollings; Avinash B Kumar; Christopher G Hughes; Antonio Hernandez; Oscar D Guillamondegui; Addison K May; Liza Weavind; Jonathan D Casey; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

8.  Power and sample size requirements for GEE analyses of cluster randomized crossover trials.

Authors:  Fan Li; Andrew B Forbes; Elizabeth L Turner; John S Preisser
Journal:  Stat Med       Date:  2018-10-08       Impact factor: 2.373

9.  Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial.

Authors:  Hanley J Ho; Yi-Roe Tan; Alex R Cook; Gerald Koh; Tat Yean Tham; Eve Anwar; Grace Shu Hui Chiang; May O Lwin; Mark I Chen
Journal:  Am J Public Health       Date:  2019-10-17       Impact factor: 9.308

10.  Randomised trial of a parenting intervention during neonatal intensive care.

Authors:  Cris Glazebrook; Neil Marlow; Christine Israel; Tim Croudace; Samantha Johnson; Ian R White; Andrew Whitelaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-02-14       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.